HALEI STEBBINS: Open Payments
NPI 1851983647 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 49 payments from 12 companies in 2025. Trend: 2023 $35 · 2024 $508 · 2025 $1,326
Food & beverage: $1,231Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $582 |
| REVANCE THERAPEUTICS, INC. | 3 | $184 |
| ABBVIE INC. | 3 | $173 |
| Lilly USA, LLC | 4 | $98 |
| UCB, Inc. | 3 | $80 |
| LEO Pharma Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
| Verrica Pharmaceuticals Inc. | 2 | $34 |
| Incyte Corporation | 1 | $26 |
| Galderma Laboratories, L.P. | 1 | $20 |
Products named: TREMFYA, DAXXIFY, BOTOX, EBGLYSS, Bimzelx, YCANTH, ANZUPGO, ILUMYA.
Industry payments across OH — which companies pay providers there.
